CONTI, Giorgio
 Distribuzione geografica
Continente #
NA - Nord America 3.098
AS - Asia 2.655
EU - Europa 1.849
SA - Sud America 295
AF - Africa 120
Continente sconosciuto - Info sul continente non disponibili 4
OC - Oceania 2
Totale 8.023
Nazione #
US - Stati Uniti d'America 2.994
SG - Singapore 1.141
CN - Cina 647
VN - Vietnam 360
IE - Irlanda 345
DE - Germania 307
FI - Finlandia 296
SE - Svezia 268
BR - Brasile 221
UA - Ucraina 188
HK - Hong Kong 187
TR - Turchia 133
ZA - Sudafrica 89
NL - Olanda 84
IT - Italia 80
FR - Francia 74
CA - Canada 73
GB - Regno Unito 67
AT - Austria 38
RU - Federazione Russa 37
AR - Argentina 30
BD - Bangladesh 26
JP - Giappone 26
IN - India 25
IQ - Iraq 21
BE - Belgio 20
PL - Polonia 16
MX - Messico 15
EC - Ecuador 13
UZ - Uzbekistan 12
PH - Filippine 9
ES - Italia 8
VE - Venezuela 8
AE - Emirati Arabi Uniti 7
CO - Colombia 7
EG - Egitto 7
KR - Corea 7
CL - Cile 6
PY - Paraguay 6
RO - Romania 6
TH - Thailandia 6
ID - Indonesia 5
LT - Lituania 5
NP - Nepal 5
PK - Pakistan 5
SA - Arabia Saudita 5
TN - Tunisia 5
AZ - Azerbaigian 4
EU - Europa 4
JM - Giamaica 4
KE - Kenya 4
AO - Angola 3
ET - Etiopia 3
JO - Giordania 3
MA - Marocco 3
TT - Trinidad e Tobago 3
TW - Taiwan 3
AU - Australia 2
BG - Bulgaria 2
BH - Bahrain 2
GE - Georgia 2
KZ - Kazakistan 2
LU - Lussemburgo 2
OM - Oman 2
PS - Palestinian Territory 2
SN - Senegal 2
AL - Albania 1
BB - Barbados 1
BO - Bolivia 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
CZ - Repubblica Ceca 1
DZ - Algeria 1
GD - Grenada 1
GT - Guatemala 1
GY - Guiana 1
HU - Ungheria 1
IL - Israele 1
IR - Iran 1
LB - Libano 1
LK - Sri Lanka 1
MY - Malesia 1
NG - Nigeria 1
NI - Nicaragua 1
NO - Norvegia 1
PA - Panama 1
PE - Perù 1
PR - Porto Rico 1
QA - Qatar 1
SC - Seychelles 1
SK - Slovacchia (Repubblica Slovacca) 1
SV - El Salvador 1
TM - Turkmenistan 1
UY - Uruguay 1
VG - Isole Vergini Britanniche 1
YE - Yemen 1
Totale 8.023
Città #
Singapore 603
Chandler 415
Dublin 345
Jacksonville 302
Ashburn 298
San Jose 271
Santa Clara 242
Hong Kong 182
Dearborn 158
Beijing 156
Izmir 119
Ho Chi Minh City 114
Munich 98
Boardman 96
Dallas 89
Johannesburg 85
Nanjing 80
Hanoi 79
Ann Arbor 78
San Mateo 72
Princeton 70
Helsinki 66
Lauterbourg 58
Toronto 49
Shanghai 48
Wilmington 48
Los Angeles 42
Vienna 38
Bremen 36
New York 32
Columbus 29
Moscow 28
Nanchang 26
Parma 26
Hebei 25
São Paulo 22
Tokyo 21
Brussels 20
Des Moines 20
Jiaxing 20
Haiphong 19
Jinan 19
Shenyang 19
Da Nang 16
Kunming 15
Tianjin 14
Turku 14
Denver 13
Hefei 13
Seattle 13
Warsaw 13
Buffalo 12
Montreal 12
Frankfurt am Main 11
London 11
The Dalles 10
Woodbridge 10
Baghdad 9
Brooklyn 9
Changsha 9
Houston 9
Council Bluffs 8
Norwalk 8
Tashkent 8
Trezzano Sul Naviglio 8
Atlanta 7
Brasília 7
Coventry 7
Salvador 7
Biên Hòa 6
Can Tho 6
Chennai 6
Mestre 6
Orem 6
Chicago 5
Grafing 5
Guayaquil 5
Londrina 5
Ottawa 5
Phoenix 5
Quito 5
Stockholm 5
Taiyuan 5
Tappahannock 5
Auburn Hills 4
Belo Horizonte 4
Bogotá 4
Düsseldorf 4
Falls Church 4
Hải Dương 4
La Plata 4
Nairobi 4
Nova Iguaçu 4
Poplar 4
Quận Ba 4
Rio de Janeiro 4
San Francisco 4
Taizhou 4
Thái Nguyên 4
Tân Tiến 4
Totale 5.080
Nome #
Activity of a synthetic microbicidal peptide against Influenza A virus multiplication 241
Inhibition of human and avian type A Influenza virus multiplication by NEK-2 treatment 202
Antibodies as a source of anti-infective peptides: an update 188
Activity of a synthetic microbicidal peptide against Influenza A virus multiplication 174
Abortive replication of influenza A viruses in HeLa 229 cells 172
Detection of IgA and IgM antibodies to HIV-1 in neonates by radioimmune western blotting. 153
Great reduction of human and avian type A Influenza virus multiplication by MESNA ( sodium-2 mercaptoethanesulfonate ) treatment. 153
Peptides from the inside of the antibodies are active against infectious agents and tumours 152
Antibodies as unlimited source of anti-infective, anti-tumor and immunomodulatory peptides 150
Defective insertion of haemagglutinin as a cause of abortivity of influenza A viruses in HeLa 229 cells. 146
Effect of coumermycin on influenza A virus replicative cycle. 135
Inhibition by prostaglandin PGA1 on the multiplication of influenza virus is a dose-dependent effect 131
Attività terapeutica di un peptide sintetico killer nei confronti di virus influenzali 128
Determinazione di anticorpi anti-HIVmediante un sistema modificato di immunoblotting 126
Therapeutic Activity of an Anti-Idiotypic Antibody-Derived Killer Peptide against Influenza A Virus Experimental Infection 124
Improved immunoblotting for the detection and quantitative analysis of antibodies to human immunodeficiency virus. 123
Chromomycin A3 inhibits influenza a virus multiplication in chick embryo fibroblast cells 123
Inhibition of multiplication of RNA genome-containing viruses performed by differentconcentrations ofMESNA 122
Different patterns of replication in influenza virus-infected KB cells 122
Biological characterization of FPV, Ulster 73, replicative cycle. 122
Inhibition of late influenza virus genome expression by diamidinophenylindole. 122
Aspetti epidemiologici delle batteriemie in Italia: osservazioni effettuate presso il Laboratorio di Microbiologia di Parma 121
Control of influenza virus polypeptide synthesis 121
Attività terapeutica di un peptide sintetico killer nei confronti di virus influenzali aviari ed umani. 120
Batteriemie da germi anaerobi 119
Restriction of Influenza virus multiplication induced by PK peptide treatment 118
Different patterns of replication in influenza virus-infected KB cells 117
Inhibition of human and avian type A Influenza virus multiplication performed by MESNA 117
Cerulenin inhibits production of mature virion particles in chick embryo fibroblasts infected by influenza A viruses. 116
The use of radioimmune western blotting to evaluate indeterminate western blotting results in blood donor HIV serodiagnosis 114
Inibizione della replicazione di virus influenzali mediante trattamento di cellule infette con un peptide sintetico killer 113
CERULENIN INHIBITS THE PRODUCTION OF MATURE VIRION PARTICLES IN CHICK EMBRYO FIBROBLASTS INFECTED BY INFLUENZA A VIRUSES 113
Inhibition of multiplication of RNA genome containing viruses performed by different concentrations of MESNA. 112
Inhibition performed by a synthetic microbicidal peptide on the replication of Influenza virus. Abstract 21.009 112
THE USE OF SODIUM 2-MERCAPTOETHANESULFONATE AS ANTIVIRAL AGENT Description not available for EP1596851 (A1) Description of corresponding document: WO2004069235 (A1) 111
Great reduction of human and avian type A Influenza virus multiplication by MESNA ( sodium-2 mercaptoethanesulfonate ) treatment 109
USE OF SODIUM 2-MERCAPTOETHANESULFONATE AS ANTIVIRAL AGENT. 109
Effetto di PGA1 e PGJ2 sulla replicazione del virus influenzale 109
Physical characterization of N4-coded messenger RNA 108
Restriction of A/WSN/33 influenza virus multiplication by prostaglandin PGJ2 108
Inhibition of multiplication of RNA genome containing viruses performed by different concentrations of MESNA. 106
Inibizione della migrazione della emoagglutinina HA del virus Ulster 73 indotta dalla prostaglandina PGA1 105
Inhibition of production of Influenza A viral particles induced by PGA1 treatment 105
Migration of influenza virus-specific polypeptides from cytoplasm to nucleus of infected cells. 102
Modification of cytoskeleton and prosome networks in relation to protein synthesis in influenza A virus-infected LLC-MK2 cells 101
ABORTIVE REPLICATION OF INFLUENZA A VIRUSES IN HELA 229 CELLS 100
Spettro d'azione universale di mimotopi killer antifungini 99
Indagine epidemiologica dei microrganismi responsabili di infezioni nosocomiali caratterizzate da batteriemie e/o fungiemie 98
RIWB in comparison with conventional WB, second and third generation ELISA assays for the serodiagnosis of HIV infection 98
Macromolecular synthesis during abortive infection of KB cells by influenza virus 98
Radioimmune western blotting in comparison with conventional western blotting, second and third generation ELISA assays for the serodiagnosis of HIV-1 infection. 96
ROLE OF ACYLATION OF VIRAL HAEMAGGLUTININ DURING THE INFLUNZA VIRUS INFECTIOUS CYCLE 96
Sepsi da catetere venoso centrale in corso di insufficienza renale. Aspetti epidemiologici e clinici. 96
GREAT REDUCTION OF HUMAN AND AVIAN TYPE A INFLUENZA VIRUS MULTIPLICATION BYMELITTIN TREATMENT 96
Inibizione della migrazione della emoagglutininaHA del virus influenzale umano WSN/33,H1N1,indotta dalla prostaglandina PGJ2 95
Phosphorylation of viral polypeptides in cells infected with influenza virus 95
Role of acylation of viral haemagglutinin during the influenza virus infectious cycle 92
THE USE OF SODIUM 2-MERCAPTOETHANESULFONATE AS ANTIVIRAL AGENT 92
Inibizione della moltiplicazione del virus influenzale umano WSN/33,H1N1,indotta dalla prostaglandina PGA1:effetto dose-dipendente 92
INHIBITION OF HUMAN AND AVIAN TYPE A INFLUENZA VIRUS MULTIPLICATION PERFORMED BY MESNA. 90
Restriction of Influenza virus multiplication induced by treatment with a yeast killer toxin-like synthetic peptide 89
Inhibitory effect of diamidinophenylindole on the replication of influena virus in permissive cellular host. 89
Viral protein synthesis during replication of bacteriophage T1. 88
THE USE OF SODIUM 2-MERCAPTOETHANESULFONATE AS ANTIVIRAL AGENT. 82
Therapeutic Activity of an Anti Idiotypic Antibody-Derived Killer Peptide against Influenza A Virus Experimental Infection 81
Radio immune Western blotting: a possible solution to indeterminate conventional Western blotting results for the serodiagnosis of HIV infections. 80
Synthesis of stable RNA in "Escherichia coli" cells infected with N4. 78
INHIBITION OF LATE INFLUENZA VIRUS GENOME EXPRESSION BY DIAMIDINEPHENILINDOLE 77
Inhibition of multiplication of RNA genome- containing viruses performed by different concentrations of MESNA. 76
Il significato delle colture intraoperatorie della parete e del trombo negli interventi per aneurisma dell'aorta addominale 68
Totale 8.036
Categoria #
all - tutte 25.508
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 25.508


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202194 0 0 0 0 0 0 0 0 0 7 77 10
2021/2022339 4 3 2 17 18 11 48 56 20 36 24 100
2022/20231.389 130 129 77 131 136 180 4 95 458 7 26 16
2023/2024339 22 37 5 8 34 76 31 26 12 8 33 47
2024/20251.570 17 83 89 71 160 255 60 65 219 112 127 312
2025/20262.604 249 228 321 235 438 201 378 70 364 120 0 0
Totale 8.036